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ABSTRACT
When cells undergo mitosis, they must replicate all six billion base pairs of DNA within
the nucleus. With the sheer volume of information, it is impossible to replicate with 100%
accuracy each time. Homologous recombination (HR) is one of many mechanisms the body has
developed to correct and repair replication errors to DNA. HR is specific to double-stranded
breaks to DNA, and it requires a sister chromatid to preserve the genetic code. BRCA1 and
Rbbp8 interact to form a complex that is heavily involved in this process. Although there is a
strong consensus about the involvement of these proteins in a cell cycle-dependent manner, there
are discrepancies in the current literature regarding when homologous recombination repair
occurs. The goal of this thesis is to elucidate the true activity of BRCA1-Rbbp8 complex in the
HR process. First, a meta-analysis was performed to review current research to understand the
various experimental protocols that led to the conflicting conclusions about cell-cycle activity of
HR. Then, we measured the mRNA levels of BRCA1 and Rbbp8 during different phases of the
cell cycle. In order to accomplish this, the cell cycle of the L cells was synchronized using
thymidine and RO-3306 for the S and G2 phases, respectively. The RNA was collected and
converted to cDNA via reverse transcriptase. Next, RT-qPCR was performed to measure the
expression of BRCA1 and Rbbp8. The levels of Rbbp8 are not significantly different between
these phases, though there was a clear downward trend worth noting. Furthermore, a statistically
significant increase in BRCA1 as the cells moved from S phase to G2 phase was observed. When
normalized to the housekeeping gene, GAPDH, the levels of mRNA for BRCA1 during the S
phase were significant lower than the control group. These results suggest that HR occurs during
both S and G2, but BRCA1 and Rbbp8 interact only during G2.
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INTRODUCTION
Specific Aims
Homologous recombination (HR) and nonhomologous end-joining (NHEJ) are
recognized as the two methods of repairing double stranded DNA breaks (DSBs) within
eukaryotic cells (Watson, 2008). NHEJ and HRR are essential to the preservation of the genetic
code. The breast cancer early onset gene 1 (BRCA1) gene and retinoblastoma binding protein 8
(RBBP8) are heavily involved in the cell-cycle dependent activity of HR (Soria-Bretones et al.,
2013). Previous research indicates that the activity of these proteins in HR is dependent upon the
cell cycle; however, there are discrepancies about the stage of the cell cycle during which it is
active. The aim of this project is to identify the time in the cell cycle in which BRCA1 and
Rbbp8 are actively repairing double-stranded DNA breaks through homologous recombination.

Cancer
Approximately 38% of all people will be diagnosed with cancer at some point during
their life, making it one of the top 10 causes of death in the world. It is a collection of different
but related diseases, all characterized by unchecked growth of cells. Cancer can be caused by
errors that occur during replication of the genome that are left uncorrected and cause the cells to
divide uncontrollably. Mutations can occur in three different types of genes that can lead to
cancer: proto-oncogenes, tumor suppressors, and DNA repair genes. When functioning normally,
these genes are all involved in normal regulation of the cell cycle and cell division. Mutations in
proto-oncogenes can result in oncogenes, and mutations can inactivate tumor suppressor genes.
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These mutated genes are then unable to properly regulate cell growth and division, and as a
result, cells continue to divide without repairing DNA or properly passing cell checkpoints. As
the cells continue to proliferate unchecked, they can encroach on normal functions of the
specialized cells and spread to other parts of the body.
There are many environmental and genetic components that interact to form the
circumstances leading to cancer. It is possible to inherit copies of genes that already contain
mutations and increase the likelihood of developing certain types of cancer. There are a number
of other risk factors for different types of cancers, including age, diet, hormone levels, infections,
and obesity. Also, carcinogenic substances, such radiation, tobacco smoke, ultraviolet rays, and
alcohol, can increase the rate of cellular mutation and can lead to cancer (National Cancer
Institute). There are over 100 different types of cancer, categorized by the type of cell that is
undergoing unchecked division, the specific organ these cells are localized within, and the
amount of damage or stage the cancer has reached.

Breast Cancer and the Genetic Component
The National Cancer Institute reports that breast cancer represents 15.2% of new cancer
cases in 2018, giving it the highest rate of incidence of any type of cancer. One of the specific
risk factors for this type of cancer is inheritance of a mutated BRCA1 or BRCA2 gene. In
humans, the BRCA1 gene is located on the long arm of chromosome 17. The 24 exons that
compose this gene code for a 1,863 amino acid protein. This tumor suppressor gene normally
functions to repair damage to the DNA and is involved in transcriptional regulation and cellcycle control. When mutated, this gene is unable to perform these functions and mutations to the
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DNA may continue to accumulate. There are a number of different mutations that have been
identified that alter the functionality of this gene, including over 750 mutations that cause the
truncation of the protein (Antoniou et al., 2003).
Inherited mutations of the BRCA1 gene are associated with an increased risk of
developing breast and ovarian cancer, increasing a person’s chance of being diagnosed with
breast cancer from 12% to 72% and ovarian cancer from 1.3% to 44%. Inheritance of a mutated
copy of BRCA1 is also linked with other types of cancer, including tumors of the fallopian tube
and peritoneum (National Cancer Institute).

Rbbp8 Background
The retinoblastoma binding protein 8 (Rbbp8), or in humans C terminal binding protein
(CtBP) interacting protein (CtIP), is an important binding factor for BRCA1 in DNA damage
repair. The Rbbp8 gene is found on chromosome 8 and contains 24 exons. This protein is part of
the family of retinoblastoma binding proteins that help regulate cell proliferation. Activation of
Rbbp8 is accomplished by the cell through phosphorylation, a crucial cyclin dependent kinase
(CDK) contingent step (Prakash et al., 2015). Rbbp8 is important in critical processes of the cell
as an endonuclease and in complex with other proteins.

Repairing Double Stranded DNA Breaks (NHEJ, MMEJ, and HR)
DNA Double stranded breaks (DSB) are lesions that can result from chemicals, radiation,
or ultraviolet light. These breaks are extremely problematic and can have severe consequences if
not repaired or if they are repaired incorrectly, such as chromosomal translocations, mutations,
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and damage to the cell. When double stranded breaks occur during the process of genome
replication, there are three different approaches the cell can pursue to repair the DNA. The first is
non-homologous end joining (NHEJ). This type of repair is active throughout the cell cycle, but
dominates in G0 and G1. NHEJ is used to directly ligate the broken ends of DNA, which leads to
the loss of base pairs (Biehs et al., 2017). The change in DNA sequence observed with NHEJ can
alter the downstream products, mRNA and proteins, formed from this sequence. For this reason,
NHEJ is not the preferred method of repairing double-stranded DNA breaks. The second
pathway is microhomology mediated end joining (MMEJ), which is also known as alternative
nonhomologous end joining. MMEJ is even more deleterious than NHEJ because it utilizes
microhomologous sequences to locally resect and align regions of complementary DNA (Yun &
Hiom, 2009).
The main pathway of DNA repair that this paper will focus on is homologous
recombination (HR). HR is a method of repairing DSBs by using the sister chromatid to correct
the error in order to conserve the DNA sequence. Due to the requirement for a sister chromatid,
HR can only occur after the DNA has already been replicated. This is the preferred method of
correcting mistakes by the cells because it is able to conserve our genetic code more effectively
than NHEJ or MMEJ. Beginning in S and G2, CDK-dependent phosphorylation of serine 327 of
Rbbp8 occurs, which activates this protein (Yun et al., 2009). Rbbp8 directly interacts with
BRCA1 C-terminal domains (BRCT) to promote and perform end resection required of the DNA
in order to effectively repair the DSB. Rbbp8 and BRCA1 also interact with the MRE11RAD50-NSB1 (MRN) complex, which effectively creates single stranded DNA through its
endonuclease activity. DNA end resection and formation of ssDNA are important steps at the
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beginning of HR that allow the RAD51 protein to direct the homologous strand exchange of the
sister chromatid in order to conserve the DNA sequence (Prakash et al., 2015).

Cell Cycle-Dependent Activity
Homologous recombination is the most accurate and preferred method of repairing DSBs
due to its use of a sister chromatid as a template for repair. This also limits the activity of HR to
phases of the cell cycle after genome replication has occurred and a sister chromatid is available,
eliminating G1. However, there have been discrepancies in the literature about whether the
BRCA1-Rbbp8 complex is active during both the S and G2 phase or only the G2 phase.
Many scientists have found that the complex is active from S phase onward (Chen et al.,
2008; Escribano-Díaz et al., 2013; Yun et al., 2009; Table 1). The techniques used in these
experiments ranged greatly; however, they all concluded that homologous recombination occurs
during both S and G2. Two experiments did yield results that led the scientists to believe that the
BRCA1-Rbbp8 complex was only active in repairing DSBs during the G2 phase of the cell cycle
(Sartori et al., 2007; Yu et al., 2004; Table 1). The experiment conducted by Sartori et al
concluded that HR was active during both S and G2 by measuring the hypersensitivity of the
DNA to camptothecin and etoposide, topoisomerase inhibitors, in CtIP depleted cells. However,
when conducting immunoprecipitation of CtIP during the S phase, they were not able to
efficiently retrieve BRCA1 as its binding partner due to the activity of the complex being solely
in G2.
Yu et al focused on the activity of BRCA1 and CtIP during the G2/M checkpoint vs the
G1/S checkpoint. These scientists found that phosphorylation of CtIP only occurred during G2,
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rather than both S and G2. Since interaction of CtIP with BRCA1 depends on its phosphorylation,
these scientists concluded that these proteins did not interact during the S phase of the cell cycle.
While they found sufficient evidence to indicate the importance of the complex at the G2 /M cell
cycle checkpoint, they did not distinguish the presence of the BRCA1-Rbbp8 complex in S
phase. A summary of the methods and conclusions found from all five of these studies can be
found in the meta-analysis (Table 1).

Table 1: Meta-analysis of current literature to determine the activity of BRCA-Rbbp8 in HR.

Publication

EscribanoDíaz et al.
(2013)

Gene
Cell Line

BRCA1
Avian B
(DT40)
Centrifugal
Elutriation
Fucci
Fluorescence
Activated
Cell Sorting
(FACS)

S

X

X

Rbbp8
Avian B
(DT40)
Centrifugal
Elutriation
CtIP -/-/mutants,
immunoprecipitation,
and western
blotting
X

G2

X

X

X

S

X

X

X

G2

X

X

X

Synchronizat
ion
Methods

Phase
when
HR is
active
Phase
when
BRCA1Rbbp8
interact

Chen et al. (2008) Yun and
Hiom (2009)
BRCA1/Rbbp8
Human (T98G)
BrdU
siRNA
transfection and
immunoprecipitation
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Sartori et al.
(2007)

Yu and Chen
(2004)

Rbbp8
Human
(U2OS)
Serum
Starvation
siRNA
mediated
depletion of
CtIP

Rbbp8
Human
(HeLa)
Thymidine
Treatment
shRNA and
immunoprecipitation

X

-

X

-

X

X

The goal of this thesis is to increase our understanding of the way that our cells undergo
homologous recombination to maintain the integrity of our DNA. In order to comprehend the
true cell-cycle dependent activity of the Rbbp8-BRCA1 complex in homologous recombination,
the levels of mRNA expression of these genes were measured during different phases of the cell
cycle (Figure 1). Hopefully, this will allow us to better understand the expression of these genes
when they are functional and how to correct mistakes when these mechanisms are not functional.
Eventually, this knowledge may help us target therapies and treatments for the cancers that
develop due to mutations in these genes.

Figure 1: Hypothesized pathway of BRCA1 and Rbbp8 expression. Labelling in red indicates factor under
investigation.
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METHODS
Cell Culture
Mus musculus L cells were used in this experiment, a strain of mouse areolar and adipose
connective tissue. In this experiment, these cells were grown in media containing Dulbecco’s
Modified Eagle Medium, 10% fetal bovine serum, and penicillin and streptomycin. Cell splitting
occurred when confluency reached approximately 80% using trypsin.

Cell Synchronization
The cells were synchronized to S or G2 phase in order to determine the RNA
concentrations during those points in the cell cycle. In order to synchronize the cells in S phase,
the cells were grown to approximately 60% confluency before being treated with 100mM
thymidine, which inhibits DNA synthesis by halting the pathway of nucleotide metabolism (Ma
et al., 2011). This causes the cells to pause in the S phase, rather than move forward through the
checkpoint into G2.
After an incubation period of 14 hours, the cells were washed with HBSS before an
addition of growth medium and 24 μM deoxycytidine. After an incubation period of 9 hours, the
cells underwent a second thymidine treatment (100mM). The purpose of the second thymidine
treatment was to retrap the cells in the S phase, which allows for stronger synchronicity. Next,
they were incubated for a period of 14 hours and then washed twice with PBS. The growth media
with 24 μM deoxycytidine was added to the plate and the cells were harvested after three hours
(Figure 2).
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Figure 2: Synchronization of cells in S phase.

For synchronization in G2 phase, the cells underwent the double thymidine block
procedure from the protocol for synchronization during S phase. After this, the cells were
incubated for approximately two hours before the addition of RO3306 (10 μM). This reagent is a
specific inhibitor of CDK1 activity which prevents the cells from moving past the next
checkpoint into mitosis. Then, the cells were incubated for an additional ten hours before
aspiration of the media and washing of the cells twice with PBS before being harvested (Figure
3). The control used was unsynchronized cells of the same passage grown through the
synchronization time period.

Figure 3: Synchronization of cells in G2 phase.
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Isolating RNA
For the technique of RNA purification, the Qiagen RNA Isolation RNeasy Mini Kit (Cat.
No. 74104) protocol was followed. RNase-free water was used to elute the column twice. A
Nanodrop Lite (ThermoFisher) was used to quantify the RNA that was purified in the sample.

RT-qPCR
For the real time quantitative polymerase chain reaction (RT-qPCR), the ThermoFisher
protocol for the Applied Biosystems High Capacity RNA-to-cDNA kit and SsoFast EvaGreen
Supermix was utilized. The DNA obtained from the reverse transcriptase reaction was diluted
1:2 with nuclease free water to a total volume of 60 μl. The reaction was run in the MiniOpticon
Real-Time PCR System (BIO-RAD). The program ran the reaction mixture at 95°C for the first
three minutes and then forty cycles of 95°C for three seconds and 60°C for thirty seconds. The
primers used for qPCR are detailed in Table 1. Analysis of the results of quantitative PCR
occurred through the 2-∆∆CT method. T-tests were then performed to determine the statistical
significance of the data obtained (SPSS).
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Table 2: Primers used for quantitative real-time polymerase chain reaction (qPCR).
*Primers not used due to nonspecific binding.
#Primer not used because only one control housekeeping gene was necessary.

Gene

Forward Primer Sequence

Reverse Primer Sequence

RBBP8-1*

CCTGTCTTCAAAACACCTCCATG

TGCAAGCTCACATCCTCCATGG

RBBP8-2

CCTCTAGTAAATTCTCTCCAGACCA

CACAAGAGAACCAGTACCCTTCA

BRCA1-1*

CCAGAAAAATGTCCGCGTAT

ACTGTCAGCCCATCTGCTCT

BRCA1-2

CGAGGAAATGGCAACTTGCCTAG

TCACTCTGCGAGCAGTCTTCAG

GAPDH

CTCATGACCACAGTCCATGC

TTCAGCTCTGGGATGACCT

B-ACTIN#

CCGTAAAGACCTCTATGCCAACA

CGGACTCATCGTACTCCTGCT
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RESULTS

B.

A.

Figure 4: Images of L cells under microscope. A. Cells are at low confluency, approximately 40-50%. B. Cells are at
high confluency ~100%.

After synchronization of the L cells to S and G2 phases, collection of mRNA, and RTqPCR to determine the relative expression levels, the 2-∆∆CT method was used to analyze the data.
First, the data of the two genes of interest, BRCA1 and Rbbp8, were normalized to the
housekeeping gene, GAPDH. Then, the values obtained for the S and G2 phases were compared
to the control, unsynchronized cells. Results from the five trials were averaged and are displayed
in Figures 1 and 2. A one-tailed Student’s t-test was then performed comparing the levels during
the S phase to G2 and comparing each individual value to the control. mRNA levels of Rbbp8
during G2 phase and S phase were not statistically significant (t4=-2.079, p=0.053), but there was
a trend for less Rbbp8 expression in G2 phase. Further studies are needed to potentially resolve
this trend. BRCA1 mRNA expression during S phase and the control was significantly less than
control (t4=-3.170, p<0.05). BRCA1 mRNA in S phase was also significantly less than G2 phase
(t4=-2.174, p<0.05).
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Fold change over unsynchronized
control cells

Expression of Rbbp8 mRNA
1.2
1
0.8
0.6
0.4
0.2
0

S Phase

G2 Phase

Figure 5: Fold change in expression of Rbbp8 mRNA in S and G2 phases. RTqPCR results of five trials underwent 2-∆∆CT analysis against unsynchronized
controls, after being normalized to GAPDH.

Fold change over unsynchronized
control cells

Expression of BRCA1 mRNA

*

1.4
1.2
1
0.8
0.6

#

0.4
0.2
0

S Phase

G2 Phase

Figure 6: Fold change in expression of BRCA1 mRNA in S and G2 phases. RT-qPCR
results of five trials underwent 2-∆∆CT analysis against unsynchronized controls, after
being normalized to GAPDH.
# The amount of mRNA of BRCA1 during S phase is statistically less than 1 (p<0.05).
* the amount of BRCA1 mRNA in S phase was significantly less than in G2 phase
(p<0.05).
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DISCUSSION
Homologous recombination is essential to the preservation of our genetic code and
integrity of our DNA. In order to resolve the discrepancies in the current literature about the cell
cycle-dependent complex of BRCA1 and Rbbp8 in HR, cells were synchronized and mRNA
expression levels of both genes were measured, following conversion to cDNA and real-time
quantitative polymerase chain reaction. After analysis with the 2-∆∆CT method, the Rbbp8 RTqPCR data indicate that the mean levels of this mRNA are fairly constant through S and G2. In
contrast, the mean mRNA levels of BRCA1 are significantly higher in G2 phase than in S phase.
We would expect the protein levels to also be higher during G2, which supports the conclusion
that the BRCA1-Rbbp8 complex is only active during the G2 phase of the cell cycle. However,
the constant levels of Rbbp8 suggests that it is active in the cell during S phase.
These results are consistent with the conclusions drawn by Sartori et al., that homologous
recombination repair occurs during S and G2 phase, but interaction between BRCA1 and Rbbp8
is only possible during G2. The consistent levels of Rbbp8 during both S and G2, and the lack of
difference between these levels and the control, show that the expression of this gene is fairly
constant. The increase in expression of BRCA1 between S and G2 shows that this gene is more
actively transcribed during G2. However, since the focus of this study was the mRNA expression
levels of these genes, it is not possible to draw concrete conclusions about the protein levels of
Rbbp8 and BRCA1.
According to the paper published by Yu and Chen, the BRCA1-Rbbp8 complex is only
active during G2, and is required for the G2/M cell cycle checkpoint, in order for the cell to begin
14

mitosis. The levels of Rbbp8 and BRCA1 mRNA dispute the claims made by Escribano-Díaz et
al., Chen et al., and Yun et al. These researchers all concluded that following phosphorylation of
Rbbp8 during S and G2, the protein interacted with BRCA1 to perform end resection required for
homologous recombination. The choice in this thesis to study mRNA expression of BRCA1 and
Rbbp8 rather than protein levels was due to a few of the previous protocols that were referenced.
While many of the publications referenced in Table 1 investigated protein levels using
immunoprecipitation, others were found to be more feasible for the time and resources available.
This study was interested in mRNA levels and we believe some inferences about protein levels
can be made from these results. However, more experiments would need to be done to test the
activity of other proteins involved homologous recombination and confirm the results from this
study that support that BRCA1-Rbbp8 interaction occurs only during G2.
This study was limited by the controls available. Due to insufficient resources,
synchronization in G1 phase or mitosis (M) was not possible as a control. Ideally, the levels of
BRCA1 and Rbbp8 in S and G2 phases would have been compared to the levels of G1 or M. It is
known that Rbbp8 participates in MMEJ during G1 (Escribano-Díaz et al., 2013). So, the levels
of Rbbp8 are more difficult to gauge based on the unsynchronized control than BRCA1.
Comparing to the unsynchronized cell mRNA levels is difficult because the cells are all in
different places in the cell cycle and each have different expression levels of the genes.
Ideally, technology such as a cell cytometers or fluorescence activated cell sorting can
distinguish and separate the cells based on their current phase of the cell cycle. In addition to
these techniques, using a gene that has known and measured levels of expression during
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the phases of the cell cycle as a positive control would have allowed confirmation that
synchronization has occurred. Unfortunately, it was not possible to locate a reliable gene with
these recognized and measured levels. However, the method of synchronization used for the L
cells was adapted and optimized from a well-established method of synchronization used on
HeLa cells with great success. For this reason, there is high confidence in the synchronization of
cells in S and G2 phases in this experiment.
Future studies could investigate if these results would apply to human cells also, by
replacing the L cells with a human cell line, such as U2OS or HeLa cells. Conducting the same
experiment to measure the levels of Rbbp8 and BRCA1 in human cells would validate these
results and allow them to be applied in the future with a higher degree of confidence. Since this
protocol only replicated one of the methods of synchronization of cells, conducting multiple
experiments using the different methods of synchronization used may give insight to if the
method of synchronization has an effect on the findings.
Also, investigation of the protein levels of BRCA1 and Rbbp8 would allow more
concrete findings as to the activity of these proteins, as this study investigated expression of the
genes. Measuring phosphorylation levels of serine 327 of Rbbp8 during the different phases of
the cell cycle may confirm the interaction of this protein with the BRCA1 C-terminal domain
(BRCT) during specific phases of the cell cycle.
An additional future project based on this research could examine how specific changes
to the levels of BRCA1 and Rbbp8 affect the genome and progression of a cell through the cell
cycle by downregulating the expression of these genes or creating knockouts. Tracking of the
16

cell through the cell cycle or sequencing of the genes to detect the rate of mutations would allow
for a deeper understanding of the role that they play in the cell.
With a clearer understanding of the activity of BRCA1 in complex with Rbbp8 in HR, we
would be able to understand the effects of the harmful mutations that affect the BRCT domain.
In learning how these genes function to promote cell growth and division in healthy cells, we can
gain a better understanding of the repercussions of what occurs when their function is impaired.
Knowledge of these proteins function and activity can direct the search for more targeted
therapies and treatments to correct the malfunctions when they may occur.

Figure 7: Confirmed pathway of expression of BRCA1 and Rbbp8.
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